Majem M, Sullivan I, Viteri S, Lopez-Vivanco G, et al. First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met. Eur J Cancer 2021;159:174-181.
PMID: 34763195